Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Rheum Dis Clin North Am ; 46(1): 61-71, 2020 02.
Artigo em Inglês | MEDLINE | ID: mdl-31757287

RESUMO

Ultrasound in rheumatology is gaining increasing acceptance in the field, with its use expanding beyond the musculoskeletal system to image rheumatic disease pathology of the vasculature, salivary glands, and lungs. Fellows in training and practicing clinicians are seeking ways to attain training and competency assessment. These standards are evolving, but no uniform mechanism for training exists. Although clinicians in practice find a wide array of resources available for self-directed education in ultrasound in rheumatology, a consensus-based and publicly available training curriculum can further enhance and standardize learning. This article discusses ultrasound in rheumatology education opportunities, competency assessment, and certification pathways.


Assuntos
Educação de Pós-Graduação em Medicina/métodos , Doenças Musculoesqueléticas/diagnóstico por imagem , Reumatologia/educação , Ultrassonografia/normas , Certificação , Competência Clínica/normas , Educação de Pós-Graduação em Medicina/normas , Avaliação Educacional/normas , Humanos , Testes Imediatos/normas , Doenças Reumáticas/diagnóstico por imagem , Reumatologia/normas
2.
JACC Case Rep ; 2(10): 1553-1557, 2020 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-34317016

RESUMO

Treatment of cardiac sarcoidosis is challenging, as the disease can be refractory to traditional treatment with steroids. Infliximab, a tumor necrosis factor-α inhibitor, has been reportedly used in cardiac sarcoidosis, but published evidence is limited. The potential cardiotoxicity of infliximab and the Food and Drug Administration black-box warning for patients with heart failure have hindered the use of this agent in cardiac sarcoidosis. Here, we report a case of refractory cardiac sarcoidosis successfully treated with infliximab and discuss the important role of fluorine-18-fluorodeoxyglucose positron emission tomography in prognostication and guidance of therapy. (Level of Difficulty: Intermediate.).

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA